171 related articles for article (PubMed ID: 12036452)
1. Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines.
Serrano MJ; Sánchez-Rovira P; Algarra I; Jaén A; Lozano A; Gaforio JJ
Jpn J Cancer Res; 2002 May; 93(5):559-66. PubMed ID: 12036452
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines.
Zoli W; Ricotti L; Barzanti F; Dal Susino M; Frassineti GL; Milandri C; Casadei Giunchi D; Amadori D
Int J Cancer; 1999 Jan; 80(3):413-6. PubMed ID: 9935183
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.
Sánchez-Rovira P; Jaén A; González E; Porras I; Dueñas MR; Medina B; Mohedano N; Fernández M; Martos M; Lozano A
Clin Breast Cancer; 2000 Oct; 1(3):226-32. PubMed ID: 11899647
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and paclitaxel in metastatic breast cancer: a review.
Colomer R
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):8-12. PubMed ID: 15685819
[TBL] [Abstract][Full Text] [Related]
5. Combination of gemcitabine antagonizes antitumor activity of paclitaxel through prevention of mitotic arrest and apoptosis.
Sui M; Xiong X; Kraft AS; Fan W
Cancer Biol Ther; 2006 Aug; 5(8):1015-21. PubMed ID: 16855376
[TBL] [Abstract][Full Text] [Related]
6. Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.
Zhu K; Gerbino E; Beaupre DM; Mackley PA; Muro-Cacho C; Beam C; Hamilton AD; Lichtenheld MG; Kerr WG; Dalton W; Alsina M; Sebti SM
Blood; 2005 Jun; 105(12):4759-66. PubMed ID: 15728126
[TBL] [Abstract][Full Text] [Related]
7. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
8. Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
Yardley DA; Brufsky A; Coleman RE; Conte PF; Cortes J; Glück S; Nabholtz JM; O'Shaughnessy J; Beck RM; Ko A; Renschler MF; Barton D; Harbeck N
Trials; 2015 Dec; 16():575. PubMed ID: 26673577
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin, paclitaxel and gemcitabine: a Phase I study of a new sequential treatment in stage III B - IV breast cancer.
Ibrahim T; Fabbri M; Frassineti GL; Zoli W; Monti M; Ricotti L; Amadori D
J Chemother; 2003 Oct; 15(5):488-94. PubMed ID: 14598942
[TBL] [Abstract][Full Text] [Related]
10. Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Rogers P; Boxall FE; Allott CP; Stephens TC; Kelland LR
Eur J Cancer; 2002 Aug; 38(12):1653-60. PubMed ID: 12142057
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.
Zielinski CC
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):36-40. PubMed ID: 14768404
[TBL] [Abstract][Full Text] [Related]
12. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic.
Papa AL; Sidiqui A; Balasubramanian SU; Sarangi S; Luchette M; Sengupta S; Harfouche R
Cell Oncol (Dordr); 2013 Dec; 36(6):449-57. PubMed ID: 24081907
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Vici P; Fabi A; Metro G; Sergi D; Giannarelli D; Di Lauro L; Bepler G; Tomao F; Cognetti F; Conti F; Lopez M
Cancer Chemother Pharmacol; 2011 Mar; 67(3):687-93. PubMed ID: 20512334
[TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling.
Oliveras-Ferraros C; Vazquez-Martin A; Colomer R; De Llorens R; Brunet J; Menendez JA
Int J Oncol; 2008 Jan; 32(1):113-20. PubMed ID: 18097549
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
[TBL] [Abstract][Full Text] [Related]
16. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant gemcitabine therapy for breast cancer.
Sánchez-Rovira P; Jaén A; Dueñas R; Porras I; Martínez E; Medina B; Mohedano N; Fernández M; Lozano A
Clin Breast Cancer; 2002 May; 3 Suppl 1():39-44. PubMed ID: 12057045
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine plus paclitaxel in breast cancer.
Yardley DA
Semin Oncol; 2005 Aug; 32(4 Suppl 6):S14-21. PubMed ID: 16143163
[TBL] [Abstract][Full Text] [Related]
19. Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial.
Sánchez-Rovira P; Jaén A; González E; Porras I; Dueñas R; Medina B; Mohedano N; Fernández M; Martos M; Lozano A; Carrasco E
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):44-7. PubMed ID: 11252890
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
Murad AM
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
